MetaCap

Apollomics Statistics

NASDAQ: APLMHealth CareBiotechnology: Pharmaceutical PreparationsUSD

21.50-0.60 (-2.71%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Apollomics by the numbers

Apollomics has a market capitalization of $62.7 million based on 2.91M shares outstanding. With trailing EPS of $-7.57, Apollomics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 4.7% below its 50-day average and 14.4% above its 200-day average.

Average daily trading volume is 21.85K shares, or about $469,840 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

APLM valuation vs. peer median

APLM compared with the median of 8 peer companies
MetricAPLMPeer medianDifference
Market cap$62.67M$60.88M+3%
Avg. volume21.85K432.17K-95%

Peer median across 8 companies: GOSS, RNXT, PLRX, ATHE, IBIO, BOLD, CNTB, XLO.

Valuation

Market cap
$62.67M
P/E (TTM)
—
Forward P/E
—
EPS (TTM)
$-7.57
Shares outstanding
2.91M

Price and trading

Previous close
22.10
Open
21.95
Day range
21.50 – 22.25
52-week range
10.01 – 42.12
52-week change
+16.64%
50-day moving average
22.56
200-day moving average
18.79
Beta
—
Volume
6.54K
Average volume
21.85K

Dividends and events

Annual dividend
None
Dividend yield
—
Ex-dividend date
—
Next earnings date
—

Additional statistics

Market Cap
62.67M
Forward Pe
-33.08
Eps
-7.57
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
42.12
Week52 Low
10.01
Avg Volume
21,853.00
Shares Outstanding
2.91M
Ma50
22.56
Ma200
18.79
Pct From52w High
-48.96%
Pct From52w Low
114.87%

Related